文献速递心律失常心力衰竭与心肌病

心脏交感神经去支配术治疗难治性室性心律失常

Cardiac Sympathetic Denervation for Refractory Ventricular Arrhythmias.
PubMed 文献 · J Am Coll Cardiol · 2017-01-01

国际多中心回顾性分析121例结构性心脏病患者,接受左侧或双侧心脏交感神经去支配术(CSD)治疗难治性室速或室速风暴。CSD后ICD电击负担从术前年均18±30次降至随访期2.0±4.3次(P<0.01),1年无持续性室速/ICD电击生存率58%,无电击、移植及死亡生存率50%。晚期心衰、较长室速周长及仅左侧手术与复发和死亡独立相关。

要点

  • CSD可显著减少难治性室速患者的ICD电击负担
  • 术前NYHA III/IV级和较长室速周长预示CSD后复发风险高
  • 仅左侧CSD与联合终点事件风险增加独立相关

核心结论

  • CSD可减少结构性心脏病患者难治性室速的持续性室速和ICD电击复发。
  • 晚期心衰、室速周长和仅左侧手术与CSD后复发及死亡独立相关。

研究设计与样本

  • 国际多中心回顾性队列研究,纳入5个中心2009至2016年121例结构性心脏病患者。
  • 患者因难治性室速或室速风暴接受左侧或双侧CSD。
  • 采用Kaplan-Meier分析ICD电击、心脏移植和死亡的无事件生存,Cox比例风险模型分析相关变量。

主要发现

  • 患者年龄55±13岁,女性26%,平均射血分数30±13%。
  • 1年无持续性室速/ICD电击生存率为58%,无ICD电击、移植和死亡生存率为50%。
  • CSD将ICD电击负担从术前年均18±30次(中位数10)降至随访中位数1.1年时的2.0±4.3次(中位数0),P<0.01。
  • 多变量分析显示,术前NYHA III/IV级心衰和较长室速周长与ICD电击复发相关。
  • 晚期NYHA心功能分级、较长室速周长和仅左侧手术预测持续性室速/ICD电击复发、死亡和移植的联合终点。

关键数值与推荐

  • 1年无持续性室速/ICD电击生存率58%,无ICD电击、移植和死亡生存率50%。
  • ICD电击负担从术前年均18±30次(中位数10)降至随访中位数1.1年时的2.0±4.3次(中位数0),P<0.01。
  • 术前NYHA III/IV级心衰和较长室速周长与ICD电击复发独立相关。
  • 晚期NYHA分级、较长室速周长和仅左侧手术预测联合终点事件。
  • 32%的患者在CSD后停用抗心律失常药物。

临床怎么用

  • 对于结构性心脏病合并难治性室速或室速风暴的患者,CSD可考虑用于减少ICD电击。
  • 术前应评估心功能分级和室速周长,以识别CSD后高复发风险患者。
  • 若选择CSD,双侧可能优于仅左侧,但需个体化评估。

局限性

  • 回顾性研究设计。
  • 样本量较小(121例)。
  • 随访时间中位数仅1.1年。
  • 仅纳入5个国际中心,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cardiac sympathetic denervation (CSD) has been shown to reduce the burden of implantable cardioverter-defibrillator (ICD) shocks in small series of patients with structural heart disease (SHD) and recurrent ventricular tachyarrhythmias (VT). OBJECTIVES: This study assessed the value of CSD and the characteristics associated with outcomes in this population. METHODS: Patients with SHD who underwent CSD for refractory VT or VT storm at 5 international centers were analyzed by the International Cardiac Sympathetic Denervation Collaborative Group. Kaplan-Meier analysis was used to estimate freedom from ICD shock, heart transplantation, and death. Cox proportional hazards models were used to analyze variables associated with ICD shock recurrence and mortality after CSD. RESULTS: Between 2009 and 2016, 121 patients (age 55 ± 13 years, 26% female, mean ejection fraction of 30 ± 13%) underwent left or bilateral CSD. One-year freedom from sustained VT/ICD shock and ICD shock, transplant, and death were 58% and 50%, respectively. CSD reduced the burden of ICD shocks from a mean of 18 ± 30 (median 10) in the year before study entry to 2.0 ± 4.3 (median 0) at a median follow-up of 1.1 years (p < 0.01). On multivariable analysis, pre-procedure New York Heart Association functional class III and IV heart failure and longer VT cycle lengths were associated with recurrent ICD shocks, whereas advanced New York Heart Association functional class, longer VT cycle lengths, and a left-sided-only procedure predicted the combined endpoint of sustained VT/ICD shock recurrence, death, and transplantation. Of the 120 patients taking antiarrhythmic medications before CSD, 39 (32%) no longer required them at follow-up. CONCLUSIONS: CSD decreased sustained VT and ICD shock recurrence in patients with refractory VT. Characteristics independently associated with recurrence and mortality were advanced heart failure, VT cycle length, and a left-sided-only procedure.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Vaseghi M, Barwad P, Malavassi Corrales FJ, et al. Cardiac Sympathetic Denervation for Refractory Ventricular Arrhythmias. J Am Coll Cardiol. 2017. PMID: 28641796. doi:10.1016/j.jacc.2017.04.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。